Vaginal pH has become the headline number of intimate care marketing. Products advertise a pH value on the front of the pack. “pH balanced” is close to a category requirement. The implication is consistent: pH is the thing that matters, and a product that delivers the right number is doing the job.
pH is genuinely important. It is also a consequence rather than a cause, and the difference matters more than it sounds.
What the number means
Healthy vaginal pH in women of reproductive age sits at roughly 3.8 to 4.5 — properly acidic, in the region of tomato juice.
That acidity is not a property of the tissue. It is produced by bacteria. Lactobacillus species ferment glycogen stored in the vaginal epithelial cells and release lactic acid as a by-product. The acid is bacterial output.
Which means pH is a readout of the microbial community. A pH of 4.2 tells you a Lactobacillus-dominant community is present and metabolically active. A pH of 5.5 tells you it is not.
The number is a symptom of the state, in the same way that a temperature reading is a symptom rather than the illness. Useful to know, not the thing to treat.
The problem with treating a readout
If acidity is produced by bacteria, then adding acid from outside does not reproduce what those bacteria do. It reproduces one of the outputs.
The protective function of a Lactobacillus-dominant community includes, at minimum:
- Continuous lactic acid production — generated constantly by a living population, not applied once and then diluted and washed away
- Both isomeric forms — L. crispatus produces D- and L-lactic acid, and research in mBio has shown the two are not biologically equivalent in their effects on extracellular matrix remodelling. External lactic acid is typically not isomer-matched
- Occupation of the surface — physical competition for epithelial attachment sites and nutrients, which makes colonisation by incoming organisms harder
- Bacteriocins — narrow-spectrum antibacterial peptides targeting specific competitors
- Immune signalling — a Lactobacillus-dominant community is associated with a quieter, less inflammatory state at the vaginal surface, which keeps the epithelial barrier intact
An acid applied to the surface delivers the first of those, transiently. It does not deliver the rest.
What the direct evidence shows
A 2011 study in BMC Infectious Diseases tested lactic acid properly: anaerobic conditions approximating the real vaginal environment, seventeen species of bacterial-vaginosis-associated bacteria, four species of vaginal lactobacilli.
At physiological concentrations (55–111 mM) and pH 4.5, lactic acid inactivated all seventeen BV-associated species and left the vaginal lactobacilli unharmed. That is a genuinely impressive result and it confirms that lactic acid is the real mechanism.
But note the conditions. Physiological concentration, sustained, in the vaginal fluid. That is what a resident bacterial population produces continuously. It is not what a wash leaves behind after rinsing.
The clinical trial evidence for externally applied lactic acid products bears this out. A systematic review of intravaginal lactic-acid-containing products for bacterial vaginosis found mixed results: of three studies comparing against first-line treatment, one found equivalence to metronidazole and two found it inferior. Of two placebo-controlled studies, one found superiority to no treatment and the other found equivalence to placebo. The reviewers concluded that high-quality evidence supporting lactic acid products for BV and for modifying the vaginal microbiota is lacking.
The in vitro data is strong. The product data is not. That gap is the whole point.
The hydrogen peroxide problem
A related claim deserves direct correction, because it is still widespread.
For years, hydrogen peroxide production by lactobacilli was presented as a key protective mechanism, and products are still marketed on the basis of hydrogen-peroxide-producing strains.
The same 2011 study tested it. At physiological concentrations (under 100 μM), hydrogen peroxide failed to inactivate any of the seventeen BV-associated species — even with human myeloperoxidase added to enhance its activity. At 10 mM it inactivated all four vaginal lactobacilli but only one of the seventeen BV-associated species. It was, in other words, more toxic to the protective organisms than to the ones it was supposed to suppress.
A 2018 analysis in Microbiome reviewed the question and argued that an in vivo antimicrobial role for hydrogen peroxide in the vagina is implausible, given the anaerobic conditions and the antioxidants present in vaginal fluid and semen.
Lactic acid is the supported mechanism. Hydrogen peroxide is not. Any product rationale resting on it is weaker than it appears.
Where pH remains genuinely useful
None of this means pH is worthless.
As a diagnostic indicator. Raised vaginal pH is one of the Amsel criteria used in diagnosing bacterial vaginosis. It is a real, informative clinical measurement.
As a marker of hormonal state. Because glycogen storage in the vaginal epithelium is oestrogen-dependent, falling oestrogen means less substrate, fewer lactobacilli, and rising pH. The pH change in genitourinary syndrome of menopause is tracking a real underlying shift.
As a formulation requirement. A product applied to vulvar skin should be compatible with the local environment. A high-pH product — ordinary soap sits around pH 9 to 10 — is a genuine disruption, and avoiding that is sensible. This is the legitimate version of the pH claim: an acidic formulation avoids doing harm. That is a lower and much more defensible claim than correcting or restoring anything.
What the better question is
Rather than “what is my pH,” the more useful question is what supports the community that produces the right pH in the first place.
What is established:
- Oestrogen status determines the food supply. Glycogen storage is oestrogen-driven, which is why the Lactobacillus-dominant state is characteristic of reproductive years and declines after menopause
- Broad-spectrum antibiotics deplete the community along with their target organism
- Douching removes it mechanically and raises pH — this is well established and consistently advised against
- Water and sanitation exposure may matter. A 2024 prospective cohort of 436 adolescent girls in Kenya found that odds of a L. crispatus-dominant community were higher with piped water than pond water, and lower with traditional pit latrines than flush toilets
What is not established is that any consumer product reliably shifts community state. Even the direct approach — administering live L. crispatus intravaginally — produced a statistically significant benefit for bacterial vaginosis recurrence but not for urinary tract infection prevention, where the confidence interval crossed 1.
The short version
pH is a useful number that tells you about the state of the vaginal microbial community. It is not the mechanism, and changing it from outside does not reproduce what the community does.
A product being pH-appropriate is a reasonable baseline — it means the product is unlikely to disrupt what is there. It is not evidence that the product restores, rebalances or protects anything, and the gap between those two claims is where most of this category’s marketing lives.
This article is general information and is not medical advice.
Sources
- O’Hanlon DE, Moench TR, Cone RA. BMC Infect Dis. 2011;11:200. doi:10.1186/1471-2334-11-200
- Tachedjian G, O’Hanlon DE, Ravel J. Microbiome. 2018;6:29. doi:10.1186/s40168-018-0418-3
- Witkin SS, et al. mBio. 2013;4(4):e00460-13. doi:10.1128/mBio.00460-13
- Plummer EL, et al. PLoS One. 2021;16(2):e0246953
- Czapar AE, et al. BMC Infect Dis. 2024;24(1):1419. doi:10.1186/s12879-024-10313-3
- Cohen CR, et al. N Engl J Med. 2020;382(20):1906-1915. doi:10.1056/NEJMoa1915254
- Stapleton AE, et al. Clin Infect Dis. 2011;52(10):1212-1217. doi:10.1093/cid/cir183
- Portman D, Gass M. J Sex Med. 2014;11(12):2865-2872
